Advancing Nanotechnology in Cancer Theranostics
A special issue of Life (ISSN 2075-1729). This special issue belongs to the section "Medical Research".
Deadline for manuscript submissions: 31 January 2025 | Viewed by 110
Special Issue Editor
Interests: biomedical devices; biomaterials; biomedical engineering; biomechanics; biomedical science; medical technology; extracellular matrix; mechanobiology; cancer metastasis; rheology; cancer cell biology; basic oncology
Special Issue Information
Dear Colleagues,
Nanotechnology plays a pivotal role in the development of innovative cancer theranostics. By leveraging nanoscale materials, researchers aim to enhance diagnostic accuracy and therapeutic efficacy. Nanoparticles can be used for metastasis detection and prediction, as well as treatment targeting. The nano-systems can carry payloads of drugs, imaging agents or both, enabling targeted delivery to tumor sites. Additionally, they facilitate the real-time monitoring of treatment responses. In summary, nanotechnology revolutionizes personalized cancer therapy by combining diagnostics and therapeutics. As we explore these groundbreaking advancements, we pave the way for effective treatments that hold immense promise for patients worldwide.
Dr. Yulia Merkher
Guest Editor
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Life is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2600 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- nanotechnology
- cancer
- nanoscale materials
- nanoparticles
- diagnostic accuracy
- therapeutic efficacy
- metastasis detection and prediction
- targeted drug delivery
- personalized cancer therapy
Benefits of Publishing in a Special Issue
- Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
- Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
- Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
- External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
- e-Book format: Special Issues with more than 10 articles can be published as dedicated e-books, ensuring wide and rapid dissemination.
Further information on MDPI's Special Issue polices can be found here.
